Ruffer’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Ruffer's REGN Position: Q3 2026 in Review
Ruffer opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 14,639 shares worth $6.3M. The stake represents 0.32% of the portfolio and ranks #76 among its holdings. This is a return to the name: Ruffer previously reported a position in REGN as recently as Q3 2025.
Ruffer first reported a position in REGN in Q3 2025 and has held it in 2 quarters since. The position peaked at $12.1M in Q3 2025. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Ruffer held 14,639 shares of Regeneron Pharmaceuticals worth $6.3M as of Q3 2026.
- Regeneron Pharmaceuticals was a new Ruffer position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.32% of Ruffer's portfolio in Q3 2026, its #76 holding.
- Ruffer first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
- Ruffer's Regeneron Pharmaceuticals position peaked at $12.1M in Q3 2025.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.